FGK Representative Service GmbH
8 products tracked · names used in filings: FGK Representative Service GmbH
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 21 Nov 2025🇪🇺 EU refusal
Atropine sulfate FGK (atropine): EU marketing authorisation refused
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Memantine FGK memantine | Application withdrawn | |
| 🇪🇺 | Atropine sulfate FGK atropine | Refused | |
| 🇪🇺 | Raligize | Application withdrawn | |
| 🇪🇺 | Corluxin mifepristone | Application withdrawn | |
| 🇪🇺 | Livmarli maralixibat | Application withdrawn | |
| 🇪🇺 | Sildenafil FGK sildenafil | Application withdrawn | |
| 🇪🇺 | Avzivi bevacizumab | Authorised | 2024-07-26 |
| 🇪🇺 | Zalviso sufentanil | Withdrawn | 2015-09-18 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.